Article Text
Therapeutics
Review: angiotensin converting enzyme inhibitors are beneficial in type 1 diabetes mellitus and microalbuminuria regardless of baseline risk factor status
Statistics from Altmetric.com
Footnotes
-
Source of funding: In part, Zeneca Pharmaceuticals
-
For correspondence: Dr N Chaturvedi, Department of Epidemiology and Public Health, Imperial College at St Mary's Norfolk Place, London W2 1PG, UK. Fax +44 (0)207 594 3392.